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ABSTRACT
The relationship between the  expression of Steroidogenic factor  1 (Sf1)  and the circadian-
related gene, period homolog 2 (Per2), in the adrenal cortex is still unknown. We show here that 
in Y1 adrenocortical tumor cells, expression of steroidogenic-related genes such as P450scc 
mRNA and Sf1 mRNA were asynchronous with Per2 mRNA. SF1 promoter analyses showed 
that the E-box element functions in a rhythmic pattern. Rhythmic expression of Upstream factor 
1  mRNA,  correlated  well  with  Sf1  mRNA expression.  We propose  that  tumorigenesis  of 
adrenocortical lesions cause disruption of synchronous expression of steroidogenic-related and 
circadian-related genes. 
INTRODUCTION
The primary adrenal form of Cushing’s syndrome is characterized by ACTH-independent 
autonomous cortisol secretion from adrenocortical tumors with diminished diurnal rhythm. The 
normal adrenal gland produces cortisol, which is stimulated by rhythmic secretion of ACTH 
from  the  pituitary  gland  driven  by  CRH  secretion  from  parvocellular  neurons  of  the 
paraventricular  nucleus  of  the  hypothalamus.  Circadian  circuits  stimulate  suprachiasmatic 
nucleus (SCN) afferents, which stimulate CRH secretion (7),(36). In addition to the activity of 
the hypothalamus-pituitary-adrenal  (HPA) axis,  the peripheral  clock of the adrenal  gland is 
known to be activated by light via the suprachiasmatic nucleus-sympathetic nervous system in 
the absence of ACTH (23).  A continuous loss of the rhythmic but robust and autonomous 
cortisol secretion from adrenal tumors is ACTH-independent. In some cases, ectopic hormone 
receptors  are  expressed  in  the  tumors,  which  aberrantly  stimulate  cortisol  secretion  (24). 
Together with activating mutations of the gene coding for the stimulatory G-protein  subunit 
(GNAS) in adrenocorticotropin-independent macronodular adrenocortical hyperplasia (AIMAH) 
(13) and mutations of protein kinase, cAMP-dependent, regulatory, type I,  gene (PRKAR1A) 
in  primary  pigmented nodular  adrenocortical  disease (PPNAD),  accumulating evidence has 
endorsed the idea that adrenocortical lesions of Cushing’s syndrome harbor abnormalities of the 
cyclic AMP signaling pathway (35).
An extensively detailed evaluation of cortisol level in patients with adrenocortical lesions of 
Cushing’s syndrome has revealed increased pulsatile secretion and a 3 h delay in phase shift 
(39). This is reminiscent of the Clock mutant mouse, where the circadian period was 27.3 h in 
constant darkness (40). It remains unclear whether the autonomous secretion of cortisol by the 
adrenal  tumor  is  induced  by  the  abnormal  rhythm of  circadian-related  genes.  Per2  is  an 
important component of the circadian clock system and participates in both the input and the 
output  pathways  of  the  clock  (3).  The  blunted  response  to  ACTH of  steroid  secretion  in 
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Although rate-limiting components of steroidogenesis, such as P450scc, show no transcriptional 
circadian  rhythm (30),  a  nuclear  factor,  Sf1/Ad4BP (Nr5a1)  is  known to  respond  to  light 
through the suprachiasmatic nucleus-sympathetic nervous system (23).
Sf1 was originally identified as an essential transcription factor that controls the expression 
of  most  steroidogenic  genes  (31).  Sf1  has  also  been  revealed  to  be  indispensable  for  the 
differentiation and development of the adrenals, gonads, and particular regions of the pituitary 
gland and hypothalamus region, based on the findings of phenotypes of Sf1 knockout mice (25). 
Thus the  modulation of  the  expression  level  or  activity  of  Sf1 in  adrenals  is  essential  for 
steroidogenesis. ACTH or  protein kinase A (PKA) have been shown to increase Sf1-mediated 
transcriptional activity, thus leading to increased steroidogenesis (11). Several mechanisms for 
this phenomenon have been proposed, including phosphorylation of Sf1 via PKA itself (43) (6) 
and via its downstream signaling, extracellular signal-regulated kinase (ERK) 1/2 (19) or by a 
dephosphorylation mechanism via mitogen-activated kinase (MAPK) phosphatase-1 (32) and 
stimulation of DAX-1 dissociation from Sf1 (32). Interestingly, because cAMP abnormalities 
have been implicated in the pathogenesis of adrenocortical lesions of Cushing’s syndrome (35), 
the  PKA-related  increase  of  Sf1  activity  may  be  associated  with  the  increased  cortisol 
production.  The expression level of  Sf1 in adrenocortical lesions of Cushing’s syndrome has 
been controversial; some reports show no change in Sf1 (33), but other studies show a moderate 
elevation (5). In the cultured adrenal cell system, no or a little increase in Sf1 level by PKA 
stimulation has been demonstrated (28). This controversy may be linked to Sf1 expression with 
respect to oscillation by circadian rhythm, thus resulting in different levels of Sf1 expression in 
adrenocortical lesions of Cushing’s syndrome. Sf1 promoter is mainly regulated by an E-box 
element to which Usf1 is known to bind in cell lines (20), leaving the question of whether Usf1 
displaces a different factor, (e.g.,  the E-box element is  also a target for circadian-regulated 
genes)  binding  the  E-box  in  normal  adrenal  tissue.  This  is  particularly  interesting  as  the 
functioning adrenocortical tumor autonomously secretes steroid hormones and the mechanism 
is not well clarified. 
The circadian-related gene, Per2, has been implicated in the development of cancer (14). 
Downregulation of Per2 has been reported in breast cancer (8; 38; 41), endometrial cancer (34), 
lymphoma cell  lines and acute myeloid leukemia patient samples  (17) and chronic myeloid 
leukemia (42). Overexpression of Per2 induces cancer cell apoptosis (22). Since adrenocortical 
lesions of Cushing’s syndrome show autonomous cortisol secretion, it is of particular interest to 
investigate whether Per2 is expressed and/or oscillates, and whether it directs the oscillation of 
steroidogenic enzyme genes in these tumors. To our knowledge, the glioma cell line is the only 
example to show tumor-related circadian rhythm of Per-2 promoter activity (15). 
In the present  study, using a  well-established activation method of circadian rhythm of 
cultured cells, namely stimulation by 50% serum shock (4), we tested the rhythmicity of Per2, 


































Sf1 and Per2 in Adrenocorticol Tumor Cells
expression of these genes which was synchronous in normal adrenal tissue.
MATERIALS AND METHODS
Cell culture and Mouse Adrenal Culture
Y1 adrenocortical  tumor  cells  were  cultured  as  previously  described  (29).  For  normal 
mouse adrenal tissue,  C57BL/6J (B6) mice were purchased from Charles River (Yokohama, 
Japan).  At  all  times  the  animals  were  treated  according  to  National  Institutes  of  Health 
guidelines. The  normal  mouse  adrenal  gland  was  dissected  from  these  mice,  cut  in  half 
(approximately 2 mg), and incubated in culture medium (Dulbecco’s Modified Eagle’s Medium 
(DMEM) + 10%(v/v) serum). 
Measurement of corticosterone and progesterone level
The corticosterone and progesterone level were determined in collaboration with SRL Co. 
Ltd. (Tokyo, Japan) using commercial RIA kits (Diagnostic Products Corp., LA, USA)
Quantitative real-time reverse transcriptase-polymerase chain reaction (RT-PCR) and 
primers
Total  RNA was  extracted  by TRizol  reagent  (Invitrogen).  Primers  used  for  amplifying 
mRNA were as follows. Mouse Per2 (forward; 5’-CAGACTCATGATGACAGAGG-3’, reverse; 
5’-GAGATGTACAGGATCTTCCC-3’),  mouse  P450scc  (forward; 
5’-AGGACTTTCCCTGCGCT-3’,  reverse;  5’-GCATCTCGGTAATGTTGG-3’),  mouse  Sf1 
(forward;  5’-CCAGGAGTTCGTCTGTCTC-3’,  reverse;  5’-  GATCCCTAATGCAAGGAG-3’) 
mouse  Usf1  (forward;  5’-GAAAACAGCTGAAACCGAAGAGGGAACAGT-3’,  reverse; 
5’-CATAGACTGAGTGGCAGGGTAACCACTGAT-3’). First-strand complementary DNA was 
synthesized using 1 g  of total RNA as the template and PCR was carried out in a LightCycler 
(Roche Diagnostics GmbH, Mannheim, Germany) according to the manufacturer’s instructions. 
Threshold values were obtained,  where fluorescent intensity was in the geometric phase of 
amplification, as determined with LightCycler Software Ver. 3.5. The expression level at each 
time-point was calibrated to those of -actin (18). 
Plasmids
The promoter-luciferase (promoter-luc) constructs of human SF-1 and human P450scc (29) 
and mouse Per2 (1) are described previously. 
Real-time monitoring of luciferase activity
Promoter activity was monitored using an in vitro real-time monitoring system (2). In brief, 
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serum-rich medium [DMEM, supplemented with 50%(v/v) serum] for two hours and replaced 
with normal medium [DMEM + 10%(v/v) serum] thereafter). After serum shock, light emission 
from the transfected cells, in the presence of 0.1 mM luciferin was measured and integrated for 
1 min at intervals of 15 min, with a photomultiplier tube (Hamamatsu Photonics).
RESULTS
 
Steroid production after serum shock in normal mouse adrenal tissue and Y1 cells.
To determine whether adrenal tumors possess intrinsic circadian rhythm of  de novo steroid 
hormone synthesis, tissues and cells were stimulated with 50% serum shock for 2 h and steroid 
hormones were measured every 4 h thereafter  (Fig.  1).  Primary culture from normal mice 
adrenal tissue (approximately 2 mg in 10 ml medium) showed small peaks of corticosterone at 
16, 24, 32, 40, 48, 56 h and an overall (circadian-like) tendency of peaks at 32 and 60 h (Fig. 
1A). Corticosterone was undetectable in mouse Y1 adrenocorticol tumor cells because these 
cells do not express steroid 21-hydroxylase (37). Instead, we measured progesterone secretion 
from Y1 cells and found an almost linear increase of progesterone up to 32 h, which was kept 
constant for up to 60 h (Fig. 1B). These results correlate well with clinical features, where 
adrenocortical tumors show autonomous secretion of steroids and normal adrenal tissue does 
not. Next we sought whether the expression of the circadian-related gene, Per2, was impaired or 
not in Y1 cells.
 
FIG. 1. Steroid secretion from normal mouse adrenal gland and Y1 adrenocortical cells after 
50% serum shock. En bloc tissue cultures of normal mouse adrenal glands (A) and Y1 cells (B) 
were  stimulated  with  50% serum for  2  h,  and  corticosterone  was  measured  by collecting 
aliquots of medium every 4 h. Data are the mean  ± SEM of three experiments.  *  represents 
significant difference from neighboring time points (p<0.05). 
mRNA expression of Per2, Sf1 and P450scc after serum shock.
Total RNA was extracted from tissue and cells at the time-points at which steroid production 
was assessed (Fig. 2). Real-time RT-PCR was performed and the relative expression of target 
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mouse adrenal tissue were quite variable but synchronous, with peaks in Per2 mRNA and Sf1 
mRNA levels at 8 and 20 h (Fig. 2A). On the other hand, Y1 cells showed a different profile. 
While Per2 mRNA showed a peak expression at 4, 28 and 52 h, with a 24-h interval (Fig. 2B, 
upper panel), Sf1 mRNA showed peaks at 4, 32, 56 h (Fig. 2B, middle panel), and P450scc 
mRNA at  12,  36,  52 h (  in  Fig.  1B,  lower  panel).  With regard to  the  highest  peak for 
Ad4BP/SF-1 mRNA (32 h) was 4 h later than for P450scc mRNA (28 h). This asynchronous 
pattern prompted us to test the promoter activity of these three genes in Y1 cells. 
FIG. 2. mRNA expression of Per2, Ad4BP/SF-1, P450scc relative to - actin after serum shock 
in en bloc tissue cultures of normal mouse adrenal glands (A) and Y1 cells (B) were evaluated 
in triplicates. Total RNA at each time-point in Fig. 1 was extracted and subjected to real-time 
RT-PCR. Data are the mean ± SEM of three experiments. and indicated where the value was 
significantly different from time 0 (p<0.05). 
Per2, SF1 and P450scc promoter activity after serum shock in Y1 cells.
To determine whether the asynchronous mRNA expression of Per2 and Sf1, P450scc in Y1 cells 
were due to asynchronous promoter activity, Per2-luc, P450scc-luc (–400 bp) and SF-1-luc were 
transfected and promoter activity was monitored using an  in vitro real-time luciferase system 
(Fig. 3). In Y1 cells, Per2-luc showed an interval of 16.5 h, but diminished thereafter (Fig. 3A). 
P450scc-luc showed a dip in promoter activity, which was restored to the same value after 19.75 
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4000, –781, –480, –92, –84 and –77 bp) (Fig. 3C) (29). A clear rhythm, with 14–16-h intervals, 
was seen in the –92-luc and longer constructs, which disappeared in the –82-luc and –77-luc 
constructs. An E-box element is known to be located between –87 and –82 bp of the human SF1 
promoter, which is the main regulatory element (29) to which USF is known to bind (20). The 
intervals of the Per-2 promoter activity was slightly longer compared with the SF1 promoter 
activity (16.5 and 14–16 h, respectively). Though a mutational analyses of the E-box element 
has not been performed, it is conceivable that promoter activity of Per-2 and Sf1 have different 
rhythms in Y1 cells. Since elements other than the E-box element seemed not to influence the 
rhythm seen in the SF1 promoter, we tested the expression of Usf1 mRNA (Fig. 3D) and found 
that it correlated well with that of Sf1 mRNA (Fig. 2B, middle graph) compared with Per2 
mRNA and Sf1 mRNA. Although the relationship between the two variables is not linear, the 
correlation values are as follows: Sf1 mRNA and Usf1 mRNA, 0.738; Sf1 mRNA and Per2 
mRNA, 0.541. This is consistent with our hypothesis that the Usf1 rhythm regulates Sf1 in Y1 
cells.
FIG. 3. Luciferase activity of Per2 (A), P450scc (B) and deletions of the Ad4BP/SF-1 (–4000, –
781, –480, –92, –84 and –77 bp) (C) promoter after serum shock in Y1 cells and evaluated by 
real-time luciferase monitoring system. A representative result of four independent experiments 
is shown. The position of the E-box element is illustrated in a cartoon of SF-1 promoter in the 
bottom panel. (D) mRNA expression of USF-1 after serum chock in Y1 cells. Total RNA at 
each time-point in Fig. 1 was extracted and subjected to real-time RT-PCR. Data are the mean ± 
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DISCUSSION
We have shown here that  adrenal  tumor-derived cells  respond to  serum shock,  which is 
known to induce the circadian expression of various genes (4). Per2 as well as Sf1 and P450scc 
genes  responded to  serum shock in  adrenal  tumor-derived  cells,  but  these  cells  could  not 
produce  steroids  in  a  circadian  fashion.  The  rhythm  of  Per2  mRNA  expression  was 
synchronized with Sf1 mRNA in normal mouse adrenal tissue, but became asynchronous in Y1 
tumor cells. This was confirmed by the promoter activity of Per2-luc and SF1-luc in Y1 cells. 
The similar expression rhythm of Per2 mRNA and Sf1 mRNA in normal adrenal tissue and the 
similar expression rhythm of Usf1 and Sf1 in the tumor-derived tissue, suggested that the E-box 
element in the SF1 promoter may be regulated by Clock/Bmal (21) (10) (16) in normal tissue 
and  by  Usf1  in  tumors.  Confirmation  of  this  awaits  direct  evidence  for  Clock/Bmal 
heterodimeric protein to regulate Sf1 in normal adrenal cells. 
With respect  to the abnormalities  of  circadian-related genes  in  adrenocortical  lesions  of 
Cushing’s  syndrome,  the  identical  3-h  shift  in  cortisol  level  of  patients  with  Cushing’s 
syndrome (39) and  Clock mutant mouse (40) led us to assume that an abnormal  Clock gene 
functions in these tumors. But because the rhythmicity of per2 mRNA was 24 h in Y1 cells 
(Fig. 2B upper panel), without a 3-h shift, the existence of a non-functional clock protein (Per2 
is regulated by Clock/Bmal) seems unlikely. 
The  sequence  of  the  E-box  of  Ad4BP/SF-1  promoter  is  5’-(–
92)AGAGTCACGTGGGGCA(–76)-3’ (E-box denoted in bold letters). This is a perfect E-box 
sequence, which is also known as a site of action for Clock/Bmal. A study of the sequences that 
surround the E-box has revealed that they are important for the decision of the E-box to function 
in a circadian or non-circadian manner (27). In this context, the E-box of SF1 promoter is 
flanked with sequences resembling that for USF binding, RY-CACGTG-RY (R for purine and Y 
for pyrimidine) (27), which has already been shown in cell lines (20). But because USF factors 
are  ubiquitous,  other  tissue  specific  factors  have  been  implicated  in  the  tissue-specific 
expression of Sf1. For example, in the testis, additional factors, besides USF, have been shown 
to bind to the E-box of Ad4BP/SF-1 promoter (9). In this respect, it is of interest to test the 
possibility that Clock/Bmal could bind to this element in normal adrenal tissue.
Adrenal tumors responsible for Cushing’s syndrome are usually in benign forms, except that 
they secrete  excess cortisol  in an ACTH-independent  fashion that  can lead to  death if  left 
untreated. Recently, Cushing’s syndrome caused by ACTH-independent bilateral adrenal tumors 
does not seem to be as rare as previously thought. In fact, recent studies have shown that rare 
inherited  bilateral  adrenal  tumors  and  sporadic  solitary  adrenal  tumors  are  linked  to 
abnormalities in cAMP signaling (reviewed in (35)). 
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circadian expression of cAMP-inducible factors such as cAMP response element modulator 
(CREM) (12), which is one of the most highly induced genes in the adrenal gland, is induced by 
light  (23).  Ad4BP/SF-1  is  also  induced  by  light  (23),  but  is  not  induced  by  cAMP.  An 
interaction between Ad4BP/SF-1 (or its post-translationally modified form) and CREB-binding 
protein  seems  to  be  important  for  coordinated  regulation  of  steroidogenic  enzymes  by 
Ad4BP/SF-1 and cAMP (26). 
Thus the asynchronous correlation (or maybe just  a bystander effect)  of cAMP-inducible 
genes, such as Ad4BP/SF-1, P450scc and circadian-related gene, Per2, in the adrenal tumors of 
Cushing’s syndrome, may be due to a defect of the adrenal circadian clock to respond at the 
time window of ACTH responsiveness. This gating mechanism has been carefully studied (30), 
but whether this can be applied to tumorigenesis awaits further investigation into the underlying 
mechanism.  We propose  a  disruption  between cAMP-inducible  genes  and circadian-related 
genes may give us a clue to the pathogenesis of the loss of circadian rhythm in these tumors. 
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